Pretransplant dyslipidaemia determines outcome in lung transplant recipients

Table 1 Baseline characteristics

	All	Survivors	Nonsurvivors	P	Without MCE	with MCE	P
	(n = 144)	(n = 108)	(n = 36)		(n = 134)	(n = 10)
Men/Women	84 (58.3%)/60 (41.7%)	66/42	25/11	0.56	81/53	7/3	0.78
Age → (yrs.)	44.8 ± 16.4	44.7 ± 16.5	49.9 ± 14.3	0.10	45.6 ± 16.1	50.9 ± 13.8	0.40
Weight (kg)	60.6 ± 16.6	58.9 ± 15.1	61.0 ± 14.2	0.81	59.6 ± 15.1	60.5 ± 13.9	0.69
Height (m)	1.67 ± 0.09	1.68 ± 0.09	1.71 ± 0.10	0.69	1.68 ± 0.09	1.71 ± 0.05	0.57
BMI (kg/m²)	21.6 ± 5.0	22.1 ± 4.2	23.5 ± 4.9	0.59	22.0 ± 4.9	22.9 ± 5.1	0.67
Creatinine (μmol/l)	75 ± 19	75 ± 18	76 ± 19	0.73	74 ± 19	87 ± 15	0.03
Urea (mmol/l)	4.4 ± 1.9	4.7 ± 1.8	4.9 ± 2.1	0.59	4.7 ± 1.8	5.4 ± 2.1	0.27
TC (mmol/l)	4.3 ± 1.6	4.2 ± 1.6	4.5 ± 1.5	0.33	4.2 ± 1.5	5.6 ± 2.0	0.007
Triglycerides (mmol/l)	1.2 ± 0.7	1.2 ± 0.7	1.3 ± 0.8	0.34	1.2 ± 0.7	1.0 ± 0.4	0.28
HDL (mmol/l)	1.5 ± 0.6	1.5 ± 0.6	1.5 ± 0.7	0.78	1.5 ± 0.6	1.9 ± 0.9	0.01
TC/HDL Ratio	3.0 ± 1.0	2.8 ± 0.7	3.6 ± 1.7	0.001	3.0 ± 1.1	2.2 ± 0.6	0.67
Underlying diseases
CF	47 (32.6%)	40	7		46	1
COPD	42 (29.2%)	30	12		37	5
IPF	30 (20.8%)	20	10	0.19	28	2	0.67
PAH	9 (6.3%)	3	6		9	0
Miscellaneous	16 (11.1%)	12	4		14	2

Data expressed as mean ± SD. Underlying diseases expressed as no. of patients and percentage of total no. of patients. BMI indicates body mass index, COPD chronic obstructive pulmonary disease, CF cystic fibrosis, HDL high-density lipoprotein, IPF idiopathic pulmonary fibrosis, PAH pulmonary arterial hypertension and TC total cholesterol. Paired T-test or chi-squared Test.

ISSN: 1476-511X